Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients

BACKGROUND: Pathological complete response (pCR) is the ultimate response in breast cancer patients treated with neoadjuvant chemotherapy (NCT). It might be a surrogate outcome for disease-free survival (DFS) and overall survival (OS). We studied the effect of clinical tumor stage (cT-stage) on tumo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast Cancer Res Treat
Main Authors: Goorts, Briete, van Nijnatten, Thiemo J. A., de Munck, Linda, Moossdorff, Martine, Heuts, Esther M., de Boer, Maaike, Lobbes, Marc B. I., Smidt, Marjolein L.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2017
Teme:
Clinical Trial
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5387027/
https://ncbi.nlm.nih.gov/pubmed/28205044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4155-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki